Povidone K30 - Polymer excipient optimizing binding and tablet durability
1. General introduction to Povidone K30
Povidone K30 is a core excipient in modern pharmaceutical formulation, where precision directly determines therapeutic efficacy and commercial success. As a water-soluble polymer with a tightly controlled K-value, Povidone K30 ensures near-perfect reproducibility in tablet manufacturing.
In large-scale production environments, even minor deviations can impact entire batches. Povidone K30 mitigates this risk through its stable rheological properties, predictable binding performance, and high compatibility with a wide range of active pharmaceutical ingredients (APIs).
2. Physicochemical properties of Povidone K30
Povidone K30 consists of Polyvinylpyrrolidone with a defined molecular weight distribution (~40,000 Da), directly influencing its viscosity and binding kinetics.
Enhanced mechanical strength: Reduces breakage and friability during packaging, transport, and storage
Process flexibility: Performs effectively in both direct compression and wet granulation processes
API protection: Stabilizes sensitive APIs through molecular interactions, minimizing degradation
Superior film-forming capability: Forms protective coatings against moisture and oxygen; Supports uniform film coating, improving surface integrity and product appearance
Global regulatory compliance:Accepted in major pharmacopeias such as USP, EP, and JP
4. Applications of Povidone K30
Povidone K30 is widely used across various pharmaceutical dosage forms, particularly in formulations requiring high mechanical strength, controlled dissolution, and system stability, critical factors determining product quality and market performance.
Solid dosage forms
Immediate release tablets: Enhances binding and ensures uniform compression
High-dose tablets: Maintains structural integrity without compromising dissolution
Effervescent tablets: Enables rapid disintegration while maintaining stability during storage
Chewable tablets: Improves cohesiveness and mouthfeel
Modified-release systems
Sustained-release tablets: Ensures uniform API distribution within matrix systems
Controlled-release formulations: Stabilizes release kinetics for consistent therapeutic outcomes
Capsules and granules
Hard capsules: Improves powder flowability and content uniformity
Wet granulation systems: Acts as a critical binder for strong and uniform granule formation
Liquid and semi solid dosage forms
Oral solutions/suspensions: Enhances solubility and stabilizes dispersion systems
Topical gels/solutions: Provides film forming properties, viscosity control and improved adhesion
One of the high value applications of Povidone K30 is its ability to form complexes with APIs through hydrogen bonding and weak intermolecular interactions. This significantly reduces the bitterness and unpleasant taste of APIs such as: Paracetamol,Guaifenesin, Other bitter or metallic tasting compounds.
This mechanism is particularly effective in oral suspensions, where palatability directly impacts patient compliance. Additionally, complex formation helps:
Prevent crystallization or precipitation
Improve physical stability of the system
Reduce dependence on sweeteners and flavoring agents
5. Sample Povidone K30 products
6. Product contact information
For more information about Povidone K30 supply, please contact us:
High-purity Chlorobutanol hemihydrate for sterile pharmaceutical applications. Effective antimicrobial activity, enhanced stability, and compliance with international standards
High-purity Citric acid anhydrous for sensitive pharmaceutical, cosmetic, and food formulations. Precise pH control, enhanced stability, and global compliance
(2).png){kind=avatar}
.png)
.png)
.png)
